Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT03508453
What this trial is testing

IC14 for Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
Implicit Bioscience
Testing effectiveness (Phase 2)UnknownNCT05860244
What this trial is testing

Effect of Salbutamol on Walking Capacity in Ambulatory ALS Patients

Who this might be right for
Walking CapacityAmyotrophic Lateral Sclerosis
Assistance Publique - Hôpitaux de Paris 36
Large-scale testing (Phase 3)Ended earlyNCT04248465
What this trial is testing

An Efficacy and Safety Study of Ravulizumab in ALS Participants

Who this might be right for
Amyotrophic Lateral SclerosisALS
Alexion Pharmaceuticals, Inc. 382
Testing effectiveness (Phase 2)Study completedNCT04821479
What this trial is testing

Repeated Mesenchymal Stem Cell Injections in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Hadassah Medical Organization 20
Not applicableLooking for participantsNCT05474235
What this trial is testing

Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders

Who this might be right for
Amyotrophic Lateral Sclerosis
Mayo Clinic 3,000
Testing effectiveness (Phase 2)Study completedNCT03488524
What this trial is testing

Open Label Extension Study of AMX0035 in Patients With ALS

Who this might be right for
Amyotrophic Lateral SclerosisALS
Amylyx Pharmaceuticals Inc. 90
Early research (Phase 1)Study completedNCT04176224
What this trial is testing

Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Japanese Patients With ALS
Shionogi 9
Not applicableWithdrawnNCT05409508
What this trial is testing

Psychological Management by Meditation of Full COnscience in Virtual REality of People With Amyotrophic Lateral Sclerosis: Effects on Cognition, Behavior, Quality of Life and Psychological Well-being

Who this might be right for
Lateral Sclerosis AmyotrophyMindfulness Meditation
University Hospital, Angers
Not applicableStudy completedNCT01495390
What this trial is testing

A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers

Who this might be right for
Amyotrophic Lateral SclerosisNervous System DiseasesSclerosis+6 more
Massachusetts General Hospital 139
Very early researchStudy completedNCT04454840
What this trial is testing

Treatment of Intravenous Infusion Plasma in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 20
Not applicableStudy completedNCT00838617
What this trial is testing

Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Vanderbilt University 10
Not applicableLooking for participantsNCT05966038
What this trial is testing

ALS/MND Natural History Study Data Repository

Who this might be right for
ALSPLSMND (Motor Neurone DIsease)+3 more
Massachusetts General Hospital 5,000
Very early researchNot Yet RecruitingNCT06689982
What this trial is testing

Tofacitinib in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Beijing Tiantan Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT00982150
What this trial is testing

Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 446
Not applicableAvailableNCT07088159
What this trial is testing

Intermediate-size Patient Population Expanded Access Protocol

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Spinogenix
Testing effectiveness (Phase 2)Study completedNCT00298597
What this trial is testing

Influence of G-CSF and EPO on Associative Learning and Motor Skills

Who this might be right for
Chronic StrokeAmyotrophic Lateral Sclerosis
University Hospital Muenster 180
Testing effectiveness (Phase 2)Ended earlyNCT05683860
What this trial is testing

Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal Dementia
Wave Life Sciences USA, Inc. 8
Not applicableNot Yet RecruitingNCT07454733
What this trial is testing

Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Trustees of Dartmouth College 800
Not applicableStudy completedNCT02880033
What this trial is testing

Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes

Who this might be right for
Parkinson's DiseaseAmyotrophic Lateral SclerosisOxidative Stress+1 more
University Hospital, Lille 90
Not applicableUnknownNCT05340660
What this trial is testing

MGluR5 Imaging in ALS Using PET

Who this might be right for
Amyotrophic Lateral Sclerosis
Nathalie Braun 30
Next Page